VBI Vaccines Balance Sheet Health

Financial Health criteria checks 2/6

VBI Vaccines has a total shareholder equity of $-5.5M and total debt of $48.7M, which brings its debt-to-equity ratio to -891.6%. Its total assets and total liabilities are $75.4M and $80.9M respectively.

Key information

-891.6%

Debt to equity ratio

US$48.75m

Debt

Interest coverage ration/a
CashUS$12.60m
Equity-US$5.47m
Total liabilitiesUS$80.91m
Total assetsUS$75.44m

Recent financial health updates

Recent updates

VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook

Sep 22

VBI Vaccines gets up to $100M debt funding from K2 HealthVentures

Sep 15

Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe

Sep 08

VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings

Aug 26

VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis

Jun 17

Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Jun 09
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?

Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Jan 24
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?

Financial Position Analysis

Short Term Liabilities: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: VBIV.Q has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: VBIV.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VBIV.Q has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: VBIV.Q is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies